🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an investigational, single arm study....
Status
Unknown
Location
Tangdu Hospital, Fourth Military Medical University
Start Date
2020-08-27
Trial ID
NCT04554524
Treatments Being Tested
This study aims to investigate the acute effects (i.e. 4 days) of paclitaxe...
Status
Terminated
Location
Institut de cancérologie Strasbourg europe
Start Date
2024-05-02
Trial ID
NCT06536556
Treatments Being Tested
This is a study evaluating the safety and effectiveness of Combretastatin A...
Status
Completed
Location
Huntsman Cancer Institute
Start Date
2005-03
Trial ID
NCT00113438
Treatments Being Tested
This study will compare overall survival in participants with Stage IIIB or...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-12
Trial ID
NCT00762034
Treatments Being Tested
This trial is a randomized, open-label Phase I-2 multi-center study designe...
Status
Unknown
Location
Ospedale Mater Salutis
Start Date
2021-03-17
Trial ID
NCT03462212
Treatments Being Tested
This clinical trial is a prospective, multicenter, open-label, randomized, ...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-01-14
Trial ID
NCT06743126
This is a single-arm, open-label, multi-center phase II study for subjects ...
Status
Completed
Location
Ironwood Cancer and Research Centers
Start Date
2017-08-22
Trial ID
NCT02549209
Treatments Being Tested
This phase I/II trial tests the safety and efficacy of split-course adaptiv...
Status
Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-05-09
Trial ID
NCT05501665
This is a multicentric study. All patients with TET (thymic epithelial tumo...
Status
Unknown
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2018-11-01
Trial ID
NCT03921671
Treatments Being Tested
This study was conducted to compare the activities of erlotinib to that of ...
Status
Terminated
Location
Lovelace Medical Group
Start Date
2006-07
Trial ID
NCT00391586
Treatments Being Tested